Yissum and Protalix BioTherapeutics Sign Agreement to License Acetylcholinestrase Development Technology

08/08/2007
YISSUM AND PROTALIX BIOTHERAPEUTICS SIGN AGREEMENT TO LICENSE ACETYLCHOLINESTRASE DEVELOPMENT TECHNOLOGY

Protalix BioTherapeutics Signs Agreement to License Acetylcholinestrase Development Technology
PR Newswire
Protalix BioTherapeutics to Explore Biodefense and Civilian Applications with Researchers from Hebrew University of Jerusalem